Article
Beckman postdoctoral associate Hsi-Chun Chao developed a new methodology to map the location and differentiate nearly identical molecules in the brain.
Completed with Professor Johnathan Sweedler and Professor Fan Lam, Chao recently published a paper about this research in the American Chemical Society’s Central Science journal. In the article, Chao and his team applied their method to study changes to these small molecules as the brain develops with age.
“I want to encourage everyone to look beyond famous biomarkers,” Chao said. “Sometimes the minor molecules are also important to study as they play important roles and can lead to significant growth in biological research.”
The brain is a complex, lipid-rich environment. Lipids are fatty compounds in which glycolipids, a class of lipids conjugated with sugar molecules, play essential roles. Brains rely on glycolipids to organize their cellular membranes and allow communication.
Metabolism is a broad term for the energetic processes that change the form of molecules by either building on or breaking off parts of the molecule. Glycolipids and other molecules go through individually specific metabolism pathways and affect various functions in the body, from movement to speech. Some molecules are similar. When two molecules share the same elemental components and mass, but have different structural organization, they’re called isomers.
So, what happens when similar molecules undergo metabolism in the brain? Is their metabolism different and how does that affect the brain? As the brain develops with age, changes in metabolism are expected, but abnormal changes associated with neurodegenerative diseases can also occur. It is important to develop ways to resolve these changes and their effect on the brain.
Chao and his team suspected they could learn valuable information about the brain’s development process by studying small molecules at the sub-cellular level using mass spectrometry. Mass spectrometry is a powerful analytical tool. It identifies various molecules from complex samples based on molecules’ specific masses after ionization.
However, conventional mass spectrometry faces significant limitations. Target isomers suffer from ion suppression because they compete for detection from more abundant non-target molecules. Distinguishing between isomers remains challenging because they share identical masses, limiting the selectivity of conventional mass spectrometry.
To overcome these limitations, researchers often combine mass spectrometry with extensive sample preparation and additional separation techniques to differentiate isomers extracted from bulk brain tissues. However, these bulk sample preparation strategies often result in the loss of critical spatial information, making it difficult to identify where abnormal metabolic changes occur within the brain.
As a result, smaller, less abundant glycolipids are rarely in the scientific spotlight, leaving a knowledge gap on the relationship between disease and these small molecules.
Chao and his team have developed a novel mass spectrometry workflow that enhances the detection of low-abundant glycolipids while distinguishing between two isomeric forms: galactosylceramides, or GalCer, and glucosylceramides, or GlcCer. This approach also enables researchers to map the location of these molecules across different regions of the aging brain. Using this workflow, Chao and his team investigated the connection between metabolism and how spatial distribution of these glycolipids changes during brain aging.
Chao found that GalCer is heavily concentrated in the corpus callosum, the middle connective bridge that allows the left and right sides of the brain to communicate. Notably, GalCer’s presence drops sharply as the brain ages. GlcCer, on the other hand, are more abundant in different regions of the brain, further suggesting that the roles these isomers play in the brain are different.
“We are pushing the boundary of mass spectrometry to perform single-cell imaging measurements to differentiate between isomers within individual cells,” Chao said. “We are developing analytical techniques for deeper investigations of human biology down to the smallest detail.”
Chao’s next direction is to visualize these isomers across a single brain cell, a neuron. Neurons are completely insulated with glycolipids. This insulated region is called the myelin and it supports neuron function. An indicator of neuron dysfunction is the collapse of the myelin.
Chao also found an isomer correlated with the myelin. He plans to further study how isomer distribution around the myelin responses with cellular aging. These results bring new insight on how similar molecules affect the brain’s development differently.
The advancements in this workflow with mass spectrometry brings researchers closer to understanding the impacts of precision medicine and establishes a foundation for future studies on glycolipids in brain aging and neurodegeneration.
By studying the location of these glycolipids as the brain ages, the specific metabolism pathways for each isomer can also be determined. This method will become useful in future studies on neurodegenerative diseases including Parkinson’s and Alzheimer’s, as they are linked to abnormal glycolipid metabolism.
Many researchers hunt for the biggest, best-known Alzheimer’s biomarkers. Chao wants people to remember that small, often overlooked molecules matter too.
This new mass spectrometry method will enable other researchers to follow Chao’s lead in investigating the function of other small molecules in the brain. The significance of Chao and his team's work was also recognized by ACS Central Science, which invited a special Reaction article highlighting their research. This recognition underscores the potential of their approach to open a new lens for investigating previously overlooked molecules and their biological roles.
Chao has collected some preliminary data suggesting the same technique can be applied at the single-cell level. Only one of the isomers appears to be localized to the myelin, the protective sheath of a neuron, in a single brain cell. This result could be an important clue in understanding the kind of neuron dysfunction associated with neurodegenerative diseases.
Chao will continue this research as an assistant professor at the University of Oklahoma in the Department of Chemistry and Biochemistry. Chao looks forward to using the university’s new equipment to delve deeper into the research he began at Beckman.
Editor’s note: The published paper, “Isomer-Resolved Mass Spectrometry Imaging Reveals Regional and Age-Dependent Glycolipid Metabolism in Rat Brain” is online at https://doi.org/10.1021/acscentsci.6c00340.
An accompanying Reaction article, published in ACS Central Science, provides a more accessible, reader-friendly overview of the research and its broader significance. It is available at https://doi.org/10.1021/acscentsci.6c01334.
Beckman Institute for Advanced Science and Technology